Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.
about
Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and PrognosticationMolecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicineNovel processed form of syndecan-1 shed from SCC-9 cells plays a role in cell migration.The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells.Syndecan-1 (CD 138) surface expression marks cell type and differentiation in ameloblastoma, keratocystic odontogenic tumor, and dentigerous cyst.Molecular changes in invasive front of oral cancer.Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma.Targeting syndecans: a promising strategy for the treatment of cancer.Integrin α11 is overexpressed by tumour stroma of head and neck squamous cell carcinoma and correlates positively with alpha smooth muscle actin expression.Sdc1 negatively modulates carcinoma cell motility and invasion.Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis.Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas.
P2860
Q26784262-252C5450-86A5-4A64-97B0-EA1C3FDBD96AQ26796247-85715EF4-03BB-49E5-81F6-1AF1FCC43DBDQ28482278-8C66C66B-1F86-47DC-BAD2-AD7C549C90A5Q33467561-67AEBA4B-5E8C-43BC-A136-6B8C09B5DB55Q34322029-9FB67B1D-BC89-4A8C-8ABD-BEB86A2B9F01Q34657627-0E46A572-39EE-49D9-AC02-7FC8E77BFF8AQ35599740-2E6C9EF1-E543-452C-B58C-348345EE5CDBQ37240372-AE8987F6-0E7B-413B-A113-6EE33BF86386Q38082795-A6808B09-7E32-409C-BB5F-543398028240Q39325272-53E81F25-20A3-405F-8CC7-8DDADE83BE76Q39494666-31CE468A-5C5E-4436-A3F4-036814E58710Q41833980-AD65CB12-298D-4B6A-8A6D-EBA00C278B64Q50883313-4AE680FB-7791-48FF-959F-6E470607B175
P2860
Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Reduced syndecan-1 expression ...... oral squamous cell carcinoma.
@en
type
label
Reduced syndecan-1 expression ...... oral squamous cell carcinoma.
@en
prefLabel
Reduced syndecan-1 expression ...... oral squamous cell carcinoma.
@en
P2093
P2860
P1476
Reduced syndecan-1 expression ...... oral squamous cell carcinoma.
@en
P2093
Hideo Kurokawa
Hiroshi Fukuyama
Kaori Igawa
Koichi Takamori
Maho Yoshida
Shinobu Matsumoto
Sumio Sakoda
Tetsu Takahashi
Toshiko Tanaka
P2860
P304
P356
10.1111/J.1600-0714.2006.00412.X
P577
2006-05-01T00:00:00Z